Avalo Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Emerald Bioventures, LLC(5.6%),Timothy Opler(5.6%)
Apr 23 15:00 ET
Avalo Therapeutics | D: Filing D
Apr 9 17:02 ET
Avalo Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(9.99%),Deep Track Biotechnology Master Fund, Ltd.(9.99%), etc.
Apr 5 16:04 ET
Avalo Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Truex Samantha
Apr 3 16:13 ET
Avalo Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Goldman Jonathan
Apr 3 16:10 ET
Avalo Therapeutics | 3: Initial statement of beneficial ownership of securities-Director KANTOFF AARON
Apr 3 16:04 ET
Avalo Therapeutics | 10-K: Annual report
Mar 29 16:08 ET
Avalo Therapeutics | 8-K: Current report
Mar 29 16:08 ET
Avalo Therapeutics | DEFA14A: Others
Mar 28 06:29 ET
Avalo Therapeutics | 8-K: Current report
Mar 28 06:14 ET
Avalo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(0.0%),VHCP Co-Investment Holdings III, LLC(0.0%), etc.
Feb 14 21:18 ET
Avalo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Great Point Partners, LLC(0.26%),Dr. Jeffrey R. Jay, M.D.(0.26%), etc.
Feb 14 17:35 ET
Avalo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nantahala Capital Management, LLC(4.9%),Wilmot B. Harkey(4.9%), etc.
Feb 14 16:58 ET
Avalo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(0.3%),Point72 Capital Advisors, Inc.(0.3%), etc.
Feb 14 10:08 ET
Avalo Therapeutics | 8-K: Current report
Jan 31 16:03 ET
Avalo Therapeutics | 8-K: Current report
Dec 28, 2023 00:00 ET
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Persson Magnus
Dec 21, 2023 16:05 ET
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Almenoff June Sherie
Dec 21, 2023 16:04 ET
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director KAPLAN GILLA
Dec 21, 2023 16:03 ET
Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chan Mitchell
Dec 21, 2023 16:01 ET
No Data
No Data